Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

- Recurrent Glioblastoma Multiforme
- Completed

Study Title: Safety and Efficacy Study to Treat Recurrent Grade 4 Malignant Brain Tumors

Teva Identifier: IXR-102-22-188

ClinicalTrials.gov Identifier: NCT00071539

Study Status: Completed

Trial Condition(s): Recurrent Glioblastoma Multiforme

Interventions: Drug: TP-38 | Drug: TP38

Study Description

Please refer to ClinicalTrials.gov for a description of the trial

Click for participation criteria and map of study locations

Key Participation Requirements

Gender: Female, Male

Age Range: 18 Years and older

Trial Duration: 10/01/2003 - 07/01/2006

Phase: Phase 2

Study Type

Interventional